British Society for Rheumatology

British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: immunomodulatory anti-rheumatic drugs and corticosteroids

2023NationalRheumatology (Oxford, England)

United Kingdom

Read the PDF Original at the sourceAsk Osler about this guideline

Read the guideline

Full guideline, as published943 KBOpen in a new tab Download

Source and rights

Published by Rheumatology (Oxford, England), 2023. The PDF is shown as published and remains the work of its authors and publisher; the original is at the source linked here. Rights holders can ask us to remove a file at info@prognia.nl.

Ask a question about this guideline.

Osler answers from this library and names the guideline behind every claim.

Discover Osler

pmc.ncbi.nlm.nih.gov/articles/PMC10070073/

Prognia summarises this guideline for reference and education. It is not medical advice. Always check the official guideline and current local protocols before acting on it.

At a glance

Organisation: British Society for Rheumatology
Published: 2023
Applies to: 🇬🇧 United Kingdom
Scope: National
Journal: Rheumatology (Oxford, England)
DOI: 10.1093/rheumatology/keac551
PubMed: 36318966
PubMed Central: PMC10070073
Added to Prognia: 22 July 2026

BSR 2026

The 2026 British Society for Rheumatology guideline for pain management in people with inflammatory arthritisBritish Society for Rheumatology · 2026Added 23 Jul 2026PDF

Clinical practice guideline for the treatment of Sjögren's disease through off-label drug use in China (English edition)Clinical rheumatology · 2026Added 18 Jul 2026PDF

Brazilian Society of Rheumatology's fibromyalgia treatment guidelines - part I: monitoring and non-pharmacological managementBrazilian Society of Rheumatology's · 2026Added 18 Jul 2026PDF

Brazilian Society of Rheumatology - 2025 recommendations on vaccination in immune-mediated rheumatic diseasesBrazilian Society of Rheumatology · 2026Added 18 Jul 2026PDF

American College of Rheumatology Guidance Statement for Diagnosis and Management of VEXAS Developed by the International VEXAS Working Group Expert PanelAmerican College of Rheumatology · 2026Added 17 Jul 2026PDF

Hypersensitivity to iodinated contrast media: Diagnostic and therapeutic strategies. Position Statement of the Drug Allergy Committee of the Mexican College of Clinical Immunology and AllergyMexican College of Clinical Immunology and Allergy · 2026Added 17 Jul 2026PDF

2025 Inborn errors of immunity practice parameter: Guidance from the Joint Task Force on Practice Parameters, the American Academy of Allergy, Asthma & Immunology (AAAAI), the American College of Allergy, Asthma and Immunology (ACAAI) and the Clinical Immunology Society (CIS)Joint Task Force · 2026Added 17 Jul 2026PDF

Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI Guidelines-2024-2025 Revision: Part I-Guidelines on Intranasal TreatmentsAllergy · 2026Added 16 Jul 2026PDF

ACR Appropriateness Criteria® Joint Pain: Idiopathic Arthritis-ChildAmerican College of Radiology · 2026Added 16 Jul 2026PDF

Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI Guidelines-2024-2025 Revision: Part II-Guidelines on Oral and Ocular TreatmentsAllergy · 2026Added 16 Jul 2026PDF